Noom Acquires 503A Compounding Pharmacy Tailor Made Compounding

by Avery Swett | Apr 2, 2026 2:54 pm | Specialty Pharmacy

Weight-loss company Noom has acquired 503A pharmacy Tailor Made Compounding, according to an April 1 press release.  Noom Tailor Made Compounding is a 503A pharmacy that provides sterile and non-sterile compounding through its pharmacy practice focused on aging. It offers compounded drugs, including hormone... Read More »

Premier Radiology Buys Teleradiology Group Global Imaging Solutions

by Avery Swett | Apr 2, 2026 2:32 pm | Laboratories, MRI & Dialysis, Private Equity

Premier Radiology Services announced the acquisition of Global Imaging Solutions, also called GLOBIS. Financial terms of the deal were not disclosed. Global Imaging Solutions, also called GLOBIS, is a teleradiology group providing subspecialty imaging interpretations to outpatient imaging centers and orthopedic practices and physician-owned... Read More »

Vision Innovation Partners Expands in Maryland 

by Kate Humphrey | Mar 31, 2026 1:41 pm | Physician Medical Groups

Vision Innovation Partners (VIP) has expanded its Maryland presence with the acquisition of Frederick Eye Institute.  Frederick Eye Institute, based in Frederick, Maryland, is a comprehensive ophthalmology practice. It specializes in cataract surgery and lens implants. The practice also employs the latest technology to provide care... Read More »

Citizens Advises Lync Health Partners on its Majority Recapitalization

by Avery Swett | Mar 31, 2026 12:28 pm | Outpatient Surgery Center

Citizens Capital Markets & Advisory has served as exclusive financial advisor to Lync Health Partners on its majority recapitalization by United Surgical Partners International. Citizens Capital Markets & Advisory is part of the institutional broker-dealer, Citizens JMP Securities, LLC, a subsidiary of Citizens Financial Group. Lync... Read More »

Eli Lilly to Acquire Centessa Pharmaceuticals for $6.3 Billion

by Avery Swett | Mar 31, 2026 12:26 pm | Biotechnology

Eli Lilly and Company announced on March 31 that it will be acquiring Boston- and London-based Centessa Pharmaceuticals. Centessa Pharmaceuticals is a clinical-stage pharmaceutical company developing a new class of drugs for the treatment of excessive daytime sleepiness and other neurological conditions. Centessa’s lead program... Read More »